Luneri

Creatine clinical brief

Creatine

Dossier liveA

Recovery

RecoveryDossier-backedDietary Supplement

Compare alternatives

Evidence strength

High confidence

163 meta-analyses - 613 RCTs - 925 tracked studies

What it is for

Skeletal muscle creatine saturation - general athletic performance and body composition

The clearest current human use case based on dose, outcomes, and clinical coverage.

What moves

Highest-signal biomarkers

Human linked

HOMA-IR

Glycemic control

Trend Toward Reduction, Not Significant

Grade A

HbA1c

Glycemic control

Decrease

Grade B

Fasting glucose

Glycemic control

Decrease

Grade B

Research signal

Top caution

Drug interaction

Additive renal hemodynamic stress.

Evidence index

Authored product-registry confidence score

Meta-analyses

163

Pooled human evidence

RCTs

613

Randomized clinical trials

Tracked studies

925

Studies currently mapped to this dossier

Clinical memoHigh confidence

Executive summary

Immediate brief

Creatine is a Recovery with its clearest current use in Skeletal muscle creatine saturation - general athletic performance and body composition.

High confidence human evidence supports the brief, anchored by 925 tracked studies, 163 meta-analyses, 613 RCTs and the most reliable movement in HOMA-IR, HbA1c, Fasting glucose.

Creatine monohydrate has an extensively studied safety record at standard doses (3-5g/day maintenance; up to 20g/day for <=5 day loading). Additive renal hemodynamic stress.

Anchor decision

Skeletal muscle creatine saturation - general athletic performance and body composition

Best current human use case

Confidence

High confidence

163 meta-analyses - 613 RCTs - 925 tracked studies

How to use this brief

1. Orient

Use the overview tab to understand mechanism, safety, scope, and where the current evidence still has blind spots.

2. Pressure-test

Move into evidence and biomarkers once the memo already makes sense, so the tables confirm or challenge the narrative rather than replace it.

3. Operationalize

Finish with dosing and PGx when the compound still looks useful and you are deciding whether it belongs in a real protocol.

CreatineDossier liveAPrimary useSkeletal muscle creatine saturation - general athletic performance and body composition

CautionDrug interaction

Major warning

Pregnancy (any trimester without medical oversight)

Creatine is safe for females at standard doses (3-5 g/day).

Overview

Clinical posture

Start with mechanism and safety, then move into scope, synergies, and the open questions that still matter before going deeper into tables.

Primary signal

Mechanism summary

Read this as the shortest defensible explanation for why the compound belongs in the conversation at all.

Phosphocreatine (PCr) acts as a rapid phosphate buffer via creatine kinase (CK), regenerating ATP from ADP during high-intensity muscle contraction and extending time to fatigue by maintaining cytosolic phosphorylation potential.

Creatine supplementation promotes skeletal muscle satellite cell activation and fusion with existing myofibers, increasing myonuclear domain size and supporting hypertrophic adaptation independent of acute mechanical load.

Elevated intracellular PCr upregulates myosin heavy chain (MHC) isoform expression, shifting fiber-type composition toward Type IIx characteristics and augmenting peak contractile force production.

The CK forward reaction (PCr + ADP → Cr + ATP) consumes one proton per cycle, buffering intracellular pH during high-glycolytic exercise and delaying acidosis-induced fatigue.

Co-primary

Safety summary

These are the reasons this compound can still break trust if the protocol fit is otherwise attractive.

Creatine monohydrate has an extensively studied safety record at standard doses (3-5g/day maintenance; up to 20g/day for <=5 day loading).

Additive renal hemodynamic stress.

Supporting context

Evidence scope

Read these caveats before assuming the effect sizes generalize cleanly across every population or use case.

Generalizability

Review

Resistance training and body composition RCTs are predominantly conducted in North American and European populations of young adult males aged 18-35.

Generalizability

Review

The largest Phase 3 RCT in a neurological population (xiao_2014, n=1741) showed no benefit for Parkinson's disease progression at 10g/day over minimum 5-year follow-up.

Generalizability

Review

Glycemic control studies included in Delpino 2022 MA are enriched for Latin American and South Asian populations with diagnosed metabolic syndrome or type 2 diabetes.

Evidence scope

Review

Cardiac outcome data in horjus_2011 Cochrane SR (n=1474) derived from hospitalized patients receiving IV phosphocreatine or cyclocreatine - not from community supplement users taking oral creatine monohydrate.

Synergies

Potential pairing logic is useful only when it adds a cleaner decision path, not when it becomes an excuse to stack indiscriminately.

Creatine + Simple carbohydrates (glucose, maltodextrin)

BDeclared

~60% greater muscle creatine accumulation vs creatine alone during loading

Creatine + Whey protein / mixed dietary protein

BDeclared

Equivalent muscle creatine retention to high-dose CHO with ~50% lower carbohydrate load; additive anabolic effect on lean mass vs either alone

Creatine + Beta-alanine

BDeclared

Additive ergogenic effect on repeated high-intensity sprint and intermittent exercise performance

Research unknowns

These are the open questions that still keep the compound from reading like a closed case.

Does creatine supplementation directly activate NF-kB inhibition in human skeletal muscle, or is the observed anti-inflammatory effect (hs-CRP, IL-6, TNF-alpha reduction) entirely secondary to reduced exercise-induced muscle damage?

What is the rate-limiting step for brain creatine accumulation in healthy omnivores, and does oral supplementation meaningfully increase cerebral PCr concentrations in populations with adequate dietary creatine intake?

What is the safety and efficacy profile of creatine supplementation in healthy children and adolescents (ages 8-17) engaged in competitive sport?

Does creatine supplementation improve cognitive outcomes in elderly populations (>=70 years) with mild cognitive impairment (MCI) or early-stage dementia, independent of exercise co-intervention?